Digestive & Intestinal Remedies (Pharmacies) - North America

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$1.48bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.49%, resulting in a market volume of US$1.59bn by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$2.90 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in North America is experiencing steady growth due to changing customer preferences, emerging trends, and local special circumstances.

Customer preferences: Customers in North America are increasingly seeking natural and organic remedies for digestive and intestinal issues. They are becoming more health-conscious and are looking for products that are free from artificial ingredients and chemicals. This shift in preferences is driving the demand for natural digestive and intestinal remedies in the market. Additionally, customers are also looking for convenient and easy-to-use products, such as capsules or tablets, that can be easily incorporated into their daily routine.

Trends in the market: One of the emerging trends in the Digestive & Intestinal Remedies market in North America is the growing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for the digestive system. They help restore the natural balance of bacteria in the gut and promote overall gut health. Probiotic supplements and foods have gained significant traction among consumers who are looking for natural ways to improve their digestive health. Another trend in the market is the increasing demand for over-the-counter (OTC) digestive remedies. OTC products are easily accessible and do not require a prescription from a healthcare professional. This convenience factor has led to a surge in the sales of OTC digestive remedies. Customers are opting for self-medication and are relying on OTC products to alleviate common digestive issues such as indigestion, heartburn, and bloating.

Local special circumstances: The North American market is characterized by a high prevalence of digestive and intestinal issues. Unhealthy dietary habits, sedentary lifestyles, and high-stress levels contribute to the increasing incidence of digestive problems in the region. This has created a significant demand for digestive and intestinal remedies in the market. Additionally, the aging population in North America is also driving the growth of the market, as older individuals are more prone to digestive issues and require specialized remedies.

Underlying macroeconomic factors: The growing awareness about the importance of digestive health and the increasing availability of digestive remedies in pharmacies are key macroeconomic factors driving the growth of the Digestive & Intestinal Remedies market in North America. Rising healthcare expenditure, improving healthcare infrastructure, and favorable government regulations are also contributing to the market growth. Furthermore, the presence of major pharmaceutical companies in the region and their continuous investments in research and development are fueling innovation and product development in the market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.